Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 407 of 1,261

  1. US 10729773

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  2. US 10729753

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  3. US 10730925

    Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

    Protalix Ltd. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  4. US 10730842

    Small molecule inhibitors of DYRK1A and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  5. US 10729651

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  6. US 10729720

    Peroxide formulations and methods and applicators for using the same

    Aclaris Therapeutics, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  7. US 10730948

    Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  8. US 10730941

    Antigen-binding proteins targeting CD56 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  9. US 10729681

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  10. US 10729697

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  11. US 10730831

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  12. US 10731172

    Regulating alkaloids

    22ND CENTURY LIMITED, LLC · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  13. US 10731154

    Acyl-amino-LNA and/or hydrocarbyl-amino-LNA oligonucleotides

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  14. US 10730949

    Method of treating PVNS with anti-CSF1R antibodies

    Five Prime Therapeutics, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  15. US 10730944

    Anti-CD8 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  16. US 10731116

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Deuteria Beverages, LLC · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  17. US 10730929

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  18. US 10730882

    2-aminoquinazoline derivatives as P70S6 kinase inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  19. US 10730871

    Immunomodulators and immunomodulator conjugates

    Regents of the University of Minnesota · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  20. US 10730854

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  21. US 10730848

    Protective molecules against anthrax toxin

    The Regents of the University of California · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  22. US 10730837

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  23. US 10729895

    Active agent delivery devices and methods of using the same

    The Regents of the University of California · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  24. US 10730835

    Thalidomide analogs and methods of use

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.